|
1
|
Choi S and Myers JN: Molecular
pathogenesis of oral squamous cell carcinoma: Implications for
therapy. J Dent Res. 87:14–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson NW, Jayasekara P and Amarasinghe
AA: Squamous cell carcinoma and precursor lesions of the oral
cavity: Epidemiology and aetiology. Periodontol 2000. 57:19–37.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sinevici N and O'sullivan J: Oral cancer:
Deregulated molecular events and their use as biomarkers. Oral
Oncol. 61:12–18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang S, Hui Y, Li X and Jia Q: Silencing
of lncRNA CCDC26 restrains the growth and migration of glioma cells
in vitro and in vivo via targeting miR-203. Oncol Res.
26:1143–1154. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang JJ, Wang DD, Du CX and Wang Y: Long
noncoding RNA ANRIL promotes cervical cancer development by acting
as a sponge of miR-186. Oncol Res. 26:345–352. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gao YL, Zhao ZS, Zhang MY, Han LJ, Dong YJ
and Xu B: Long noncoding RNA PVT1 facilitates cervical cancer
progression via negative regulating of miR-424. Oncol Res.
25:1391–1398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hua F, Li CH, Chen XG and Liu XP: Long
noncoding RNA CCAT2 knockdown suppresses tumorous progression by
sponging miR-424 in epithelial ovarian cancer. Oncol Res.
26:241–247. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng HT, Shi DB, Wang YW, Li XX, Xu Y,
Tripathi P, Gu WL, Cai GX and Cai SJ: High expression of lncRNA
MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Int J Clin Exp Pathol. 7:3174–3181. 2014.PubMed/NCBI
|
|
11
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu B, Lei D, Wang L, Yang X, Jia S, Yang
Z, Shan C, Yang X, Zhang C and Lu B: MiRNA-101 inhibits oral
squamous-cell carcinoma growth and metastasis by targeting zinc
finger E-box binding homeobox 1. Am J Cancer Res. 6:1396–1407.
2016.PubMed/NCBI
|
|
13
|
Jiang M, Xu B, Li X, Shang Y, Chu Y, Wang
W, Chen D, Wu N, Hu S, Zhang S, et al: O-GlcNAcylation promotes
colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2
regulatory feedback circuit. Oncogene. 38:301–316. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen L, Jia J, Zang Y, Li J and Wan B:
MicroRNA-101 regulates autophagy, proliferation and apoptosis via
targeting EZH2 in laryngeal squamous cell carcinoma. Neoplasma.
66:507–515. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin Q, He W, Chen L, Yang Y, Shi K and You
Z: MicroRNA-101-3p inhibits proliferation in retinoblastoma cells
by targeting EZH2 and HDAC9. Exp Ther Med. 16:1663–1670.
2018.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bertone P, Stolc V, Royce TE, Rozowsky JS,
Urban AE, Zhu X, Rinn JL, Tongprasit W, Samanta M, Weissman S, et
al: Global identification of human transcribed sequences with
genome tiling arrays. Science. 306:2242–2246. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang H, Chen Z, Wang X, Huang Z, He Z and
Chen Y: Long non-coding RNA: A new player in cancer. J Hematol
Oncol. 6:372013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang D, Yang Z, Long F, Luo L, Yang B, Zhu
R, Sang X and Cao G: Inhibition of MALAT1 reduces tumor growth and
metastasis and promotes drug sensitivity in colorectal cancer. Cell
Signal. 57:21–28. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yao Y, Chen X, Lu S, Zhou C, Xu G, Yan Z,
Yang J, Yu T, Chen W, Qian Y, et al: Circulating long noncoding
RNAs as biomarkers for predicting head and neck squamous cell
carcinoma. Cell Physiol Biochem. 50:1429–1440. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhuo M, Yuan C, Han T, Cui J, Jiao F and
Wang L: A novel feedback loop between high MALAT-1 and low
miR-200c-3p promotes cell migration and invasion in pancreatic
ductal adenocarcinoma and is predictive of poor prognosis. BMC
Cancer. 18:10322018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu Y, Zhang X, Hu X, Zhou W, Zhang P,
Zhang J, Yang S and Liu Y: The effects of lncRNA MALAT1 on
proliferation, invasion and migration in colorectal cancer through
regulating SOX9. Mol Med. 24:522018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pan Y, Tong S, Cui R, Fan J, Liu C, Lin Y,
Tang J, Xie H, Lin P, Zheng T and Yu X: Long non-coding MALAT1
functions as a competing endogenous RNA to regulate vimentin
expression by sponging miR-30a-5p in hepatocellular carcinoma. Cell
Physiol Biochem. 50:108–120. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang XJ, Xia Y, He GF, Zheng LL, Cai YP,
Yin Y and Wu Q: MALAT1 promotes angiogenesis of breast cancer.
Oncol Rep. 40:2683–2689. 2018.PubMed/NCBI
|
|
25
|
Zhu K, Ren Q and Zhao Y: lncRNA MALAT1
overexpression promotes proliferation, migration and invasion of
gastric cancer by activating the PI3K/AKT pathway. Oncol Lett.
17:5335–5342. 2019.PubMed/NCBI
|
|
26
|
Lin N, Yao Z, Xu M, Chen J, Lu Y, Yuan L,
Zhou S, Zou X and Xu R: Long noncoding RNA MALAT1 potentiates
growth and inhibits senescence by antagonizing ABI3BP in
gallbladder cancer cells. J Exp Clin Cancer Res. 38:2442019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stone JK, Kim JH, Vukadin L, Richard A,
Giannini HK, Lim SS, Tan M and Ahn EE: Hypoxia induces cancer
cell-specific chromatin interactions and increases MALAT1
expression in breast cancer cells. J Biol Chem. 294:11213–11224.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou X, Liu S, Cai G, Kong L, Zhang T, Ren
Y, Wu Y, Mei M, Zhang L and Wang X: Long Non-coding RNA MALAT1
promotes tumor growth and metastasis by inducing
epithelial-mesenchymal transition in oral squamous cell carcinoma.
Sci Rep. 5:159722015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang SM and Hu WW: Long non-coding RNA
MALAT1 promotes oral squamous cell carcinoma development via
microRNA-125b/STAT3 axis. J Cell Physiol. 233:3384–3396. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pan L, Chen H, Bai Y, Wang Q and Chen L:
Long non-coding RNA CASC2 serves as a ceRNA of microRNA-21 to
promote PDCD4 expression in oral squamous cell carcinoma. Onco
Targets Ther. 12:3377–3385. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang P, Liu Y, Li C, Zhang L, Liu Q and
Jiang T: LncRNA PAPAS promotes oral squamous cell carcinoma by
upregulating transforming growth factor-β1. J Cell Biochem.
120:16120–16127. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang C, Bao C, Zhang X, Lin X, Pan D and
Chen Y: Knockdown of lncRNA LEF1-AS1 inhibited the progression of
oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Cancer Biol Ther. 20:1213–1222. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu Q, Xiang L, Chen Z, Liu X, Ou H, Zhou J
and Yang D: MALAT1 functions as a competing endogenous RNA to
regulate SMAD5 expression by acting as a sponge for miR-142-3p in
hepatocellular carcinoma. Cell Biosci. 9:392019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Guo W, Li Z, Wu Y, Jing C, Ren Y,
Zhao M, Kong L, Zhang C, Dong J, et al: Role of the EZH2/miR-200
axis in STAT3-mediated OSCC invasion. Int J Oncol. 52:1149–1164.
2018.PubMed/NCBI
|
|
35
|
Hong Y, He H, Sui W, Zhang J, Zhang S and
Yang D: Long non-coding RNA H1 promotes cell proliferation and
invasion by acting as a ceRNA of miR-138 and releasing EZH2 in oral
squamous cell carcinoma. Int J Oncol. 52:901–912. 2018.PubMed/NCBI
|
|
36
|
Zhang D, Ni Z, Xu X and Xiao J: miR-32
functions as a tumor suppressor and directly targets EZH2 in human
oral squamous cell carcinoma. Med Sci Monit. 20:2527–2535. 2014.
View Article : Google Scholar : PubMed/NCBI
|
